Enhance Med Management Outcomes with Advanced Services

Omnicell’s Advanced Services, powered by a connected intelligent infrastructure, are enhancing business and clinical outcomes across inpatient to outpatient settings.

Case Study

Temple University Hospital Improves Drug Access, Revenue with Specialty Pharmacy

Temple University Hospital partnered with Omnicell to launch an in-house specialty pharmacy in just five months, increasing sales by 45%.


3 Key Considerations to Optimize Your Specialty Pharmacy

Explore how to set up your specialty pharmacy operations for enhanced clinical outcomes and support ongoing success.


Safety and Savings in IV Automation

Hear how Huntsville Hospital has enhanced safety and is achieving savings through technology-driven sterile compounding.

Case Study

Texas Children’s Hospital Leverages Central Pharmacy Robotics for ADC Replenishment

Read how a leading pediatric hospital partnered with Omnicell to support their unique needs for patient-specific and cabinet-restocking medications.

Latest News

Pharmacy Robot Dispenses Orders at Christ Hospital

Cincinnati-based Christ Hospital introduced Omnicell’s XR2 robot in June to support inpatient medication dispensing, dispensing around 6,000 doses a day.


Facing the Looming Nursing Shortage Head-On

Prominent healthcare experts discuss how to limit the impact of nursing shortages through an intelligent infrastructure of technology and data intelligence.

More Resources

Explore a variety of informative materials to inspire your journey to an autonomous pharmacy

Case Study

Archbold Medical Center Achieves Medication Inventory Visibility and Optimization

Learn how better inventory insight helped Archbold to realize significant cost savings and improve other aspects of medication management.


Federal 340B Ruling Underscores Need for Balanced Pharmacy Program

A recent ruling by a Philadelphia federal appeals court could introduce more barriers to specialty drugs for health systems that don’t have an in-house specialty pharmacy.